XML 39 R19.htm IDEA: XBRL DOCUMENT v3.21.1

Stockholders’ Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of stock option granted was estimated using the Black-Scholes assumption

Exercise price		$	1.92-11.00
Expected dividend yield			0	%
Risk free interest rate			0.28%-2.65	%
Expected life in years			2.70-10.00
Expected volatility			141-151	%

Schedule of analysis of the stock option grant activity under the plan

Stock Options		Number				Weighted Average Exercise Price				Weighted Average Remaining Life
Outstanding December 31, 2019			1,102,500			$	4.00				7.77
Granted			1,045,500				2.32				8.91
Expired or forfeited			(5,000	)			1.92				-
Outstanding December 31, 2020			2,143,000			$	3.18				7.81

Warrants		Number				Weighted Average Exercise Price				Weighted Average Remaining Life
Outstanding December 31, 2019			1,382,478				4.44				2.84
Granted			8,906,381				6.24				5.00
Expired or forfeited			(190,810	)			8.12				-
Exercised			(4,298,903	)			7.20				-
Outstanding December 31, 2020			5,799,146			$	5.05				4.00

Schedule of nonvested option

Nonvested Options		Shares				Weighted- Average Exercise Price
Nonvested at December 31, 2019			-			$	-
Granted			1,045,500				2.32
Vested			(67,500	)			2.93
Expired or forfeited			(5,000	)			1.92
Nonvested at December 31, 2020			973,000			$	2.28

Nonvested Warrants		Shares				Weighted- Average Exercise Price
Nonvested at December 31, 2019			200,000				4.00
Granted			8,906,381				6.24
Vested			(4,296,668	)			5.14
Expired or forfeited			(4,489,713	)			7.24
Nonvested at December 31, 2020			320,000			$	3.69

X

- References

No definition available.

+ Details

Name:	adtx_ScheduleOfAnalysisOfTheStockOptionGrantActivityUnderThePlanTableTextBlock
Namespace Prefix:	adtx_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration